EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children

Kevin M Watt, Elizabeth J Thompson iD, Lisa Lam, Kanecia Zimmerman, Christoph P Hornik, Andrew M Atz, Allison Fernandez, Susan R Hupp, Varsha Bhatt-Mehta, Daniel K Benjamin, Ravinder Anand, Michael Cohen-Wolkowiez und 4 weitere

The Journal of Clinical Pharmacology · 2026

DOI: 10.1002/jcph.70143 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Pharmacology, 2026. Verfasst von Kevin M Watt und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of Utah, Salt Lake City, UT, USA. Hauptthemen laut MEDLINE: Methadone, Analgesics, Opioid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methadone is used in hospitalized children to treat pain and iatrogenic opiate withdrawal. Optimal pediatric dosing for both enteral and intravenous methadone is unknown. We conducted two prospective, multi‐center, open‐label studies to characterize the pharmacokinetics of methadone in the pediatric population. These studies were conducted at a total of 23 US children's hospitals. Ninety‐nine children with a median (range) age of 2.3 (0–19.0) years and weight of 13.0 (0.72–159) kg were prescribed methadone per standard of care for treatment of pain or iatrogenic opiate withdrawal. Ninety‐nine children received median (range) methadone doses of 0.11 (0.01–0.39) mg/kg intravenously and 0.10 (0.01–0.61) mg/kg enterally. Ten participants received only intravenous doses; 78 received only enteral doses; and 11 received intravenous and enteral doses. We analyzed 263 pharmacokinetic samples with a median (range) methadone plasma concentration of 42.2 (0.9–729.2) ng/mL. A one‐compartment population pharmacokinetic model described the methadone data well. Median (range) empiric Bayesian estimates of clearance, volume of distribution, and half‐life were 0.17 (0.009–1.50) L/h/kg, 4.99 (0.97–20.6) L/kg, and 20.5 (3.0–86.2) h, respectively. Dosing simulations showed that doses of 0.1 mg/kg every 8 h (intravenous) and 0.2 mg/kg every 8 h (enteral) achieved exposures associated with pain control and reduction in withdrawal symptoms. Based on observed exposures and model simulations, we recommend a starting dose of 0.1 mg/kg intravenous or 0.2 mg/kg enterally (max 10 mg) every 8 h. Because of wide interindividual variability, this dose should be titrated to effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethadoneAnalgesics, OpioidHumansMaleChildChild, PreschoolFemaleAdolescentInfantProspective StudiesAdministration, IntravenousYoung AdultModels, BiologicalBayes TheoremHalf-Life

Stichwörter der Autor:innen

childrendosingmethadoneobesitypharmacokinetics

Substanzen

MethadoneAnalgesics, Opioid

Autor:innen und Institutionen

  • University of Utah, Salt Lake City, UT, USA.
  • Duke University Medical Center, Durham, NC, USA.
  • Duke Clinical Research Institute, Durham, NC, USA.
  • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA.
  • Medical University of South Carolina, Charleston, SC, USA.
  • Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.

ORCID-Profile: Elizabeth J Thompson, Daniel Gonzalez

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Watt, K. M., Thompson, E. J., Lam, L., Zimmerman, K., Hornik, C. P., Atz, A. M., Fernandez, A., Hupp, S. R., Bhatt-Mehta, V., Benjamin, D. K., Anand, R., Cohen-Wolkowiez, M., Gonzalez, D., Smith, P. B., Capparelli, E. V., & Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee (2026). Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70143

Vancouver

Watt KM, Thompson EJ, Lam L, Zimmerman K, Hornik CP, Atz AM, et al. Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children. The Journal of Clinical Pharmacology. 2026. doi:10.1002/jcph.70143

BibTeX
@article{Watt2026,
  author = {Watt, Kevin M and Thompson, Elizabeth J and Lam, Lisa and Zimmerman, Kanecia and Hornik, Christoph P and Atz, Andrew M and Fernandez, Allison and Hupp, Susan R and Bhatt-Mehta, Varsha and Benjamin, Daniel K and Anand, Ravinder and Cohen-Wolkowiez, Michael and Gonzalez, Daniel and Smith, P Brian and Capparelli, Edmund V and Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee, Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee},
  title = {Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children},
  journal = {The Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/jcph.70143}
}
Kostenlos starten →